NEOMED Institute, Saint-Laurent, Canada

Resident companies

RELEVANT PLAYERS IN THE LIFE SCIENCES ECOSYSTEM

The small molecules site (Saint-Laurent) hosts strategic companies playing a key role in the life sciences value chain. Our resident companies offer services in medicinal chemistry, assay development, DMPK, intellectual property, and strategic recruitment consulting. We are continuously evolving and will continue to populate the site with entrepreneurial companies operating predominantly in the development of small molecule therapeutics.

Neomed Institute Logo

NEOMED Institute

NEOMED Institute is a not-for-profit drug discovery and development organization whose mission is to foster the development of promising therapeutic approaches emerging from academia and biotechnology companies. We support the development of projects up to the stage of human proof of concept. We operate in a virtual mode using the services of our Saint-Laurent and Laval facilities.

NEOMED Institute is jointly funded by the pharmaceutical industry, the Ministère de l’Économie, de l’Innovation et des Exportations du Québec, and the Networks of Centres of Excellence (NCE) of Canada.

Paraza Logo

PARAZA PHARMA, INC.

An innovative company with an aim to significantly improve efficiency of drug discovery process from lead identification through lead optimization to development candidates. With an excellent team of highly creative drug discovery scientists trained in world reputed laboratories and deep experience in drug discovery & development from pharmaceutical companies such as Merck, Pfizer, Wyeth, Schering-Plough, AstraZeneca and Boehringer-Ingelheim, we offer collaborative opportunities to provide most efficient solutions.

For more information, please visit our website:
www.parazapharma.com

neomed-amplia-pharmatek

AMPLIA PHARMATEK INC.

Amplia PharmaTek Inc. is a unique drug discovery and development service provider focused on serving the needs of our clients in Discovery Biology, Disease Pharmacology and non-GLP Toxicology. The passion of Amplia PharmaTek’s team is to deliver customer-oriented, collaborative, comprehensive and cost-effective services to emerging Biotech companies, academic institutions and non-profit research organizations.

For more information, please visit our website:
www.ampliapharmatek.com

Intellisyn Logo

INTELLISYN R&D

A medicinal chemistry-focused R&D organization specializing in identifying novel leads and optimizing them as successful clinical candidates. We have an established track record with clinical candidates in psychosis, depression, Alzheimer’s and pain. We provide full discovery support (computational chemistry, design, synthesis, and DMPK) to our partners in pharma and biotech where innovation and proven delivery-expertise are needed.

For more information, please visit our website:
www.intellisynrd.com

enGene Logo

enGene

enGene is leader in nucleotide delivery to the intestine. The Company has developed a highly flexible nucleotide (DNA and RNAi) delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels. enGene’s platform technology has the ability to significantly impact diseases of mucosal tissues such as the gastrointestinal tract, lung and bladder as well as provide systemic delivery of therapeutic proteins from the gut to treat diabetes, anemia, hemophilia and others. The Company is initially applying its technology to localize delivery of immune-modulating proteins to the intestinal mucosa for treating inflammatory bowel disease.

For more information, please visit our website:
www.engeneinc.com

Cyclenium Pharma Logo

CYCLENIUM PHARMA

Cyclenium Pharma is an emerging pharmaceutical research and development company pursuing development of selected product opportunities in areas of unsatisfied medical need, while simultaneously creating a second generation macrocyclic drug discovery technology. We are building value through progression of our internal programs, and establishing collaborations with innovative pharmaceutical and biotechnology companies seeking to drug difficult disease targets.

For more information, please visit our website:
www.cyclenium.com

Crocus Laboratories Logo

CROCUS LABORATORIES INC.

Our team has extensive experience in drug discovery/medicinal chemistry – particularly in the areas of oncology, infectious diseases, and ophthalmology. We are seeking collaborations and partnerships with academic groups, biotech, and pharmaceutical companies with the goal to discover and develop novel medicines.

For more information, please visit our website:
www.crocuslaboratories.com

KDM laboratories Logo

KDM LABORATORIES INC.

KDM is a contract research organization providing services to the biotech and pharmaceutical industry. We offer services to help clients identify key aspects in PK, PD, and metabolism to move projects forward. These services include analytical and bioanalytical method development/validation, analytical and bioanalytical analysis of samples in various in vitro, preclinical and clinical matrixes, impurity and metabolite structure elucidation, and experimental evaluation of physical chemistry and pharmaceutical properties including drug metabolism, drug-drug interaction, plasma protein binding, solubility, stability, and formulations.

For more information, please visit our website:
www.kdmlabs.com

Aptochem Logo

APTOCHEM

AptoChem specializes in the custom synthesis of stable labeled (D, 13C,15N) and radiolabeled (14C) reference standards, test articles, pharmaceuticals and their metabolites. AptoChem can synthesize a wide variety of small molecules and fine chemicals in the milligram to gram scale. Our goal is to provide our clients with a specialized custom synthetic chemistry service of the highest quality in the industry at the lowest possible price and in shortest possible turnaround time.

For more information, please visit our website:
www.aptochem.com

Robic Logo

ROBIC, LAWYERS, PATENT AND TRADEMARK AGENTS

Founded in 1892, ROBIC, L.L.P. is an internationally renowned firm of lawyers, patent and trade-mark agents specialized in Intellectual Property and Business Law. Headquarted in Montreal, ROBIC is a Canadian firm with more than 175 people including 23 partners and 45 professionals. We provide dynamic and entrepreneurial assistance and representation to clients in executing business transactions in addition to managing, protecting, enforcing and commercialising their intellectual capital.

For more information, please visit our website:
www.robic.ca

Progeneca logo

PROGENECA BIOTECH INC.

Progeneca Biotech provides quality services to small and large biotech companies as well as to the academic sector. Amongst the services we provide are gene cloning, expression, purification of proteins and small molecules, protein modification, protein characterization, in-vitro assays using spectrophotometer, fluorescence, HPLC and chromatography based assays, biomarkers enrichment & proteomics, mass spectrometry analyses, Pre-IND and IND filing and consultancy. We have vast experience in Analytical methods development as required by FDA and its Canadian and European counterparts. Our expertise in protein drug R&D, from cloning to purified protein product, can shorten R&D time and can facilitate faster drug development processes.

For more information, please visit our website:
www.progeneca.com

Chorus Logo

CHORUS

Chorus, an autonomous division of Eli Lilly and Company, is an early phase drug development group that cost-effectively advances candidate molecules from discovery through clinical Proof of Concept (PoC).

The Chorus mission is to deliver definitive, quality PoC data enabling our business partners to efficiently sort a large stream of innovative candidates. The goal of Chorus is to deliver PoC data that permits informed go-no go investment decisions and, in the case of successful assets, drives a large step-up in probability of technical success and value. We do this by combining an integrated, virtual drug development platform with a more efficient drug development paradigm to deliver best-in-industry productivity. Taking the Chorus approach to early stage development, our business partners can markedly reduce the cost of early technical attrition while maintaining a call back option for promising assets.

For more information, please visit our website:
www.choruspharma.com

Langue Consulting Logo

LANGE CONSULTING

Founded in 2004, Lange Consulting is a human resources consulting company specialized in the strategic management of human resources offering a variety of services such as, implementation of compensation strategies, performance review programs, management of competencies, pay equity programs, coaching of executives and managers as well as the management of recruitment. In addition, Lange Consulting offers companies a personalized service of outsourcing of human resources management (“HR in the box”).

Composed of an experienced team of consultants in human resources, Lange Consulting has accumulated over 30 years of experience across North America and Europe in Life Sciences, Information Technology, Telecommunications, Industrial Technologies, Service Organizations as well as in the manufacturing sector.

For more information, please visit our website:
www.langeconsultants.com

BioAuxilium Logo

BIOAUXILIUM RESEARCH

Assay development is a complex process than can rapidly become a bottleneck in both basic research and drug discovery laboratories. BioAuxilium Research provides customized services in biochemical, cell-based and biomarker assay development across a number of therapeutic areas using various high-throughput technology platforms.

BioAuxilium also offers preclinical sample testing services using no-wash immunoassay technologies. Regardless of the scope of your project, we can design and develop a robust, sensitive and reproducible assay that will meet your requirements and expectations.

For more information, please visit our website:
www.bioauxilium.com

Domain Therapeutics Logo

DOMAIN THERAPEUTICS NA INC.

Domain Therapeutics NA is the Canadian subsidiary of Domain Therapeutics, a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G Protein-Coupled Receptors (GPCRs), one of the most important classes of drug targets.

Domain Therapeutics discovers GPCR drugs by exploiting its innovative and differentiated technologies. The company’s pipeline is composed of new chemical entities, ranging from hits to preclinical candidates for significant CNS and metabolic disorders.

Establishing a presence in Montreal is part of the company’s strategy for bringing to market a new GPCR-specific biosensor technology, BioSens-All(TM), developed at the Institute of Research in Immunology and Cancer (IRIC) of the University of Montreal in the team of Professor Michel Bouvier. BioSens-All(TM) technology enables a deeper understanding of the GPCR signaling pathways that are activated by each candidate molecule and thus predict its pharmacological profile.

For more information, please visit our website:
www.biosensall.com

Cerebrasol Logo

CEREBRASOL LTD.

Cerebrasol Ltd. specializes in the design and delivery of focused preclinical research packages, using electrophysiological recording techniques for nervous system indications such as pain, neurodegeneration (Alzheimer’s and Parkinson’s disease), psychiatric disorders, movement disorders and obesity. We prepare your compounds for clinical development by providing a flexible, highly skilled service with fast turnaround tailored to our clients’ needs, delivering key proof-of-concept, drug efficacy, mechanism of action data and more.

For more information, please visit our website:
www.cerebrasol.com

Medesis Logo

MEDESIS PHARMA

Formed in 2003, Medesis Pharma is a clinical-stage, Franco-Canadian biopharmaceutical company developing innovative strategies for the delivery of water-soluble active ingredients, employing a novel nano-sized water-in-oil microemulsion (Aonys®). The Aonys® technology, protected by several international patent families, provides a non-invasive systemic delivery of active ingredients to target cells using an extremely efficient cellular penetration method.

Using this technology, the company is targeting two therapeutic applications:

  • The decorporation of radioactive metals, allowing efficient decontamination following accidental contamination (in partnership with the CEA, France)
  • The delivery of metal ions, allowing the treatment of neurodegenerative diseases such as Huntington’s disease, together with metabolic diseases (two products currently in clinical trials)

In addition to these strategic applications, the technology is being applied to the delivery of peptides and oligonucleotides, with a particular emphasis on oncology and CNS applications.

For more information, please visit our website:
www.medesispharma.com

Inception sciences logo

INCEPTION SCIENCES CANADA

Inception Sciences Canada is a small molecule drug discovery company. Our focus is creating high-value therapies with transformative potential to address diseases and disorders with significant unmet needs. Through partnerships with academic experts, we are translating biological insights into first-in-class drugs.

For more information, please visit our website:
www.inceptionsciences.com

STATUSCENT

STRATUSCENT BIO

Stratuscent Inc. develops CLOUDSENSE, an electronic nose platform. CLOUDSENSE is a ubiquitous chemical sensing platform technology that can quantify and identify chemical footprints that are omnipresent in our environment. The ability to sense chemical fingerprints in a ubiquitous computing environment can provide the context to the decision making process in smart devices.

For more information, please visit our website:
www.stratuscent.com

Banook Group

Banook Group

Banook Group is one of the few established international providers capable of supplying cardiac safety, central imaging and endpoint adjudication services to pharmaceutical, medical device and biotech companies, CROs and nonprofit organizations. Its mission is to help its clients invent tomorrow’s healthcare, using qualitative, reliable and innovative solutions in early to late stage clinical trials and ultimately to bring new solutions to the market for the benefit of patients worldwide. Its medical and regulatory expertise, quality-driven approach and team availability make the Banook Group a key player for clinical trial services.

For more information, please visit our website: www.banookgroup.com

Rapare_logoEN

Repare Therapeutics

Repare Therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare’s platform combines a proprietary, high throughput, CRISPR‐enabled gene editing target discovery method with high‐resolution protein crystallography, computational biology and clinical informatics.

For more information, please visit our website: www.reparerx.com

© 2017 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia